IRMD
IRadimed Corporation
NASDAQ · USHealthcareMedical - Devices
$97.03+0.00%
Price as of Jul 20, 2026
IRMD profitability
IRadimed Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 76.8%
- EBITDA margin
- 37.4%
- EBIT margin
- 32.4%
- Net margin
- 27.4%
- Free cash flow margin
- 27.9%
Returns
- Return on equity
- 24.0%
- Return on assets
- 20.6%
- Return on invested capital
- 28.4%
- Asset turnover
- 0.77x
Cash efficiency
- Cash from operations
- $28.9M
- Cash per share
- $4.41
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.